5th International Conference on
Otolaryngology-ENT Surgery
November 26-27, 2026 | Dubai, UAE
Dubai, UAE
Immunotherapy in Head & Neck Cancer
Immunotherapy in Head & Neck Cancer
Immunotherapy in Head& Neck Cancer focuses on harnessing the patient’s immune system to recognize and eliminate malignant cells in head and neck malignancies. This session will highlight recent advances in immuno-oncology, clinical trial outcomes, and combination treatment strategies that are transforming the management of head and neck cancers, with an emphasis on improving survival, reducing toxicity, and personalizing therapy.
- Immune checkpoint inhibitors in head and neck squamous cell carcinoma
- Tumor microenvironment and immune modulation in head and neck cancer
- Biomarkers for predicting response to immunotherapy
- Management of immune-related adverse events
- Role of immunotherapy in recurrent and metastatic disease
- Emerging vaccines and adoptive cell therapies
- Translational research and future directions in head and neck cancer immunotherapy
Related Sessions
Tags
- Immunotherapy in Head & Neck Cancer Conferences
- Head and Neck Cancer Immunotherapy Conference
- Cancer Immunotherapy in Otolaryngology Conferences
- ENT Oncology Conferences
- Immunotherapy in Head & Neck Cancer Congress
- Head and Neck Oncology Congress
- ENT Cancer Immunotherapy Congress
- Otolaryngology Oncology Congress
- Immunotherapy in Head & Neck Cancer Event
- ENT Oncology Event
- Cancer Immunotherapy Events
- Otolaryngology Oncology Events
- Immunotherapy in Head & Neck Cancer Meetings
- Head and Neck Oncology Meetings
- ENT Cancer Immunotherapy